MRD positivity was the poor prognostic factor for adverse-risk AML patients with allogeneic hematopoietic stem cell transplantation: a multicenter TROPHY study
Main Authors: | Yang Cao, Wenxuan Huo, Jiayu Huang, Yang Yang, Yu Wang, Yingjun Chang, Luxiang Wang, Zilu Zhang, Chuanhe Jiang, Xiaoxia Hu, Xiaodong Mo |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2024-01-01
|
Series: | Blood Cancer Journal |
Online Access: | https://doi.org/10.1038/s41408-024-00976-1 |
Similar Items
-
Diagnostic efficiency of metagenomic next-generation sequencing for suspected infection in allogeneic hematopoietic stem cell transplantation recipients
by: Jiayu Huang, et al.
Published: (2023-09-01) -
MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AML
by: Katrin Teich, et al.
Published: (2023-08-01) -
Generalist in allogeneic hematopoietic stem cell transplantation for MDS or AML: Epigenetic therapy
by: Guancui Yang, et al.
Published: (2022-10-01) -
MRD in AML: The Role of New Techniques
by: Maria Teresa Voso, et al.
Published: (2019-07-01) -
COVID-19 in immunocompromised patients after hematopoietic stem cell transplantation: a pilot study
by: Zilu Zhang, et al.
Published: (2024-04-01)